Kieviet, N, Dolman, KM, Honig, A. The use of psychotropic medication during pregnancy: how about the newborn?
Neuropsychiatr Dis Treat
Levinson-Castiel, R, Merlob, P, Linder, N, Sirota, L, Klinger, G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med
Sie, SD, Wennink, JMB, van Driel, JJ
et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed
Moses-Kolko, EL, Bogen, D, Perel, J
et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA
Ferreira, E, Carceller, AM, Agogue, C
et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics
Ray, S, Stowe, ZN. The use of antidepressant medication in pregnancy. Best Pract Res Clin Obstet Gynaecol
Ververs, T, Kaasenbrood, H, Visser, G, Schobben, F, de Jong-van den Berg, L, Egberts, T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol
Oberlander, TF, Misri, S, Fitzgerald, CE, Kostaras, X, Rurak, D, Riggs, W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry
Laine, K, Heikkinen, T, Ekblad, U, Kero, P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry
Klinger, G, Merlob, P. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Isr J Psychiatry Relat Sci
Davidson, S, Prokonov, D, Taler, M
et al. Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr Res
Jansson, LM, Velez, M. Neonatal abstinence syndrome. Curr Opin Pediatr
Field, T, Diego, M, Hernandez-Reif, M. Prenatal depression effects and interventions: a review. Infant Behav Dev
Byatt, N, Deligiannidis, KM, Freeman, MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand
Oberlander, TF, Warburton, W, Misri, S, Aghajanian, J, Hertzman, C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry
Hilli, J, Heikkinen, T, Rontu, R
et al. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. Eur Neuropsychopharmacol
Finnegan, LP, Kron, RE, Connaughton, JF, Emich, JP. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm
18. American Society of Health-System pharmacists. AHFS Drug Information 2012. ASHP, Maryland, United States, 2012.
19. Definition of ilicit drugs by the United Nations Office on Drugs and Crime. Available at www.unodc.org. Accessed August 1, 2015.
Roelofs-Thijssen, MAMA, Schreuder, MF, Hogeveen, M, van Herwaarden, AE. Reliable laboratory urinalysis results using a new standardised urine collection device. Clin Biochem
Boix, F, Wøien, G, Sagvolden, T. Short term storage of samples containing monoamines: ascorbic acid and glutathione give better protection against degradation than perchloric acid. J Neurosci Methods
Hessels, J, Cairo, DW, Slettenhaar, M, Dogger, M. PeeSpot; urine home collection device Innovatieve methode voor verzamelen van portie urine. Ned Tijdschr Klin Chem Labgeneesk
van Praag, HM. Psychofarmaca. Assen, the Netherlands, van Gorcum, 2001.
Berg, C, Backström, T, Winberg, S, Lindberg, R, Brandt, I. Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus. PLoS One
Zigmond, AS, Snaith, RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand
Herrmann, C. International experiences with the Hospital Anxiety and Depression Scale – a review of validation data and clinical results. J Psychosom Res
27. Dutch birgweight curves, Dutch perinatal registration.Available at www.perinatreg.nl. Accessed August 1, 2015.
Kieviet, N, van Ravenhorst, M, Dolman, KM
et al. Adapted Finnegan scoring list for observation of anti-depressant exposed infants. J Matern Fetal Neonatal Med
Twisk, JWR. Applied Longitudinal Data Analysis for Epidemiology. Cambridge: Cambridge University Press, 2013.
Peters, DA. Maternal stress increases fetal brain and neonatal cerebral cortex 5-hydroxytryptamine synthesis in rats: a possible mechanism by which stress influences brain development. Pharmacol Biochem Behav
Pawluski, JL, Galea, LAM, Brain, U, Papsdorf, M, Oberlander, TF. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics
Marc, DT, Ailts, JW, Campeau, DCA, Bull, MJ, Olson, KL. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: validity and clinical applicability. Neurosci Biobehav Rev
Esler, M, Lambert, E, Alvarenga, M
et al. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress
Birkenhäger, TK, van den Broek, WW, Fekkes, D, Mulder, PG, Moleman, P, Bruijn, JA. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. Prog Neuropsychopharmacol Biol Psychiatry
Sarrias, MJ, Cabré, P, Martínez, E, Artigas, F. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem
Tellez, MR, Mamikunian, G, O’Dorisio, TM, Vinik, AI, Woltering, EA. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs). Pancreas